tiprankstipranks
Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
US Market
BLRX
Bioline RX Ltd Sponsored ADR
RESEARCH TOOLSreports

Bioline RX Ltd Sponsored ADR (BLRX) Stock News & Sentiment

2,544 Followers
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
Premium
Ratings
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
17d ago
BLRX
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
Premium
Company Announcements
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
19d ago
6K
BLRX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
22d ago
LAR
MBX
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
22d ago
AIR
CCL
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
Premium
Company Announcements
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
22d ago
6K
BLRX
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Bioline RX Ltd Sponsored ADR (BLRX) Q4 Earnings Cheat Sheet
1M ago
BLRX
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
Premium
Company Announcements
BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute
2M ago
6K
BLRX
More BLRX News >

BLRX News on the Web

BioLineRx, Hemispherian initiate clinical trial of GLIX1
TipRanks News
Bullish
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
TipRanks News
Bullish
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
TipRanks News
Neutral
BioLineRx initiates Phase 1/2a study of GLIX1
TipRanks News
Bullish
BioLine Rx Ltd (BLRX) Full Year 2025 Earnings Call Highlights: Navigating Challenges and ...
GuruFocus News
Neutral
Full Year 2025 BioLine RX Ltd Earnings Call Transcript
GuruFocus News
Neutral
Options Volatility and Implied Earnings Moves Today, March 23, 2026
TipRanks News
Neutral
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
BLRX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLRX’s Media Buzz Sentiment?
1 articles about BLRX were published this week. In an average week, 2.75 articles are published.
    What is BLRX’s weekly average amount of articles?
    In an average week, 2.75 articles about BLRX are published.
      What is BLRX’s News Sentiment?
      100% of articles about BLRX were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        STAAStaar Surgical
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        Showing the stocks with the most bullish news sentiment over the past week